Stakk Lands US Healthcare Deal Pushing Annualised Revenue Run Rate to $26M
Stakk secures U.S. healthcare tech contract, pushing annualised revenue run rate to $26 million
Stakk Ltd (ASX: SKK) has signed a new U.S. healthcare technology customer expected to contribute approximately A$3.85 million (US$2.75 million) in annualised revenue. The addition lifts the company’s annualised revenue run rate from A$22.08 million (announced 28 April 2026) to approximately A$26.0 million, representing a 2,067% increase since December 2024 when the run rate stood at just A$1.2 million. The first quarterly payment is expected to be received prior to 30 June 2026, placing it within the company’s Q4 FY26 cash position.
When big ASX news breaks, our subscribers know first
Contract details at a glance
The agreement, comprising a Master Services Agreement together with a corresponding Service Order Form, was signed by Stakk on 29 May 2026 (U.S. time) and by the client on 1 June 2026 (U.S. time), with an initial term of two years and mutual extension provisions.
The deployment involves the implementation of customised trust and decisioning workflows designed to validate and match a user’s digital credentials against the individual presenting them prior to access being granted across healthcare-related services and environments. The solution combines real-time identity validation, document authenticity analysis, federated signal intelligence, and deterministic decisioning capabilities to assist in ensuring interactions are initiated only where the presenting user has been verified within an authenticated digital context.
The customer is a privately held health technology platform headquartered in New York, United States. Its identity has been withheld under commercial confidentiality obligations pursuant to the terms of the agreement.
| Metric | Detail |
|---|---|
| Annual Revenue Contribution | ~A$3.85 million (US$2.75 million) |
| Contract Term | Initial two years, mutual extension provisions |
| Commercial Structure | Fixed-term platform licensing + customised workflow and data intelligence models |
| Billing Structure | Quarterly payments in advance |
| First Cash Receipt | Expected prior to 30 June 2026 (Q4 FY26) |
From A$1.2 million to A$26 million — understanding annualised revenue run rate
Annualised revenue run rate is a mathematical extrapolation of current recurring and contracted revenue contributions. It is not a forecast or statutory revenue figure, and investors should understand what it does and does not capture.
In practice, Stakk’s booked revenue for the twelve months ending 30 June 2026 is expected to be materially lower than the stated annualised revenue run rate. This is because a number of customer contracts commenced progressively throughout the financial year and were therefore not operational for the full twelve-month reporting period.
Despite this limitation, annualised revenue run rate remains a meaningful supplementary metric for investors. It captures the scale and trajectory of revenue growth at a point in time, reflecting the cumulative value of all contracted customers active at that date. The progression milestones for Stakk are:
- December 2024: A$1.2 million (post-Radical DBX, Inc. acquisition close)
- 28 April 2026: A$22.08 million (previously announced)
- 2 June 2026: A$26.0 million (current, post this contract)
That represents a total increase of 2,067% since December 2024. All U.S. dollar conversions referenced in this announcement apply an AUD/USD exchange rate of 0.7143, equating to approximately A$1.40 for every US$1.00.
Annualised revenue run rate is not a substitute for statutory revenue reported under applicable accounting standards and should not be relied upon in isolation.
The next major ASX story will hit our subscribers first
Why this deal matters for Stakk’s investment case
Healthcare validates the multi-vertical platform strategy
This contract win represents further validation of Stakk’s stated strategy: deploying a single AI-native Digital Trust infrastructure layer across multiple regulated industry verticals. The same underlying platform that serves existing enterprise clients is being extended into healthcare, reinforcing both platform scalability and the potential for sustained margin improvement as new verticals are added without rebuilding core infrastructure.
The verticals Stakk is actively targeting include:
- Financial services
- Telecommunications
- Healthcare
- Government
- Enterprise systems
- Physical-digital access environments
The healthcare deployment is not a bespoke standalone build. It draws on the same platform capabilities already in production across Stakk’s existing client base, which management believes supports efficient replication across new regulated environments.
Replacing legacy SaaS — the enterprise demand driver
Enterprise demand for Stakk’s platform is being driven by the growing inadequacy of fragmented legacy SaaS architectures that were not originally designed to manage cumulative workflows. According to the announcement, organisations operating in regulated industries face five specific risk categories that existing infrastructure is increasingly unable to address:
- Synthetic identities
- Manipulated digital signals
- Account takeover risk
- Real-time fraud orchestration
- Autonomous decisioning requirements
Stakk’s existing client base comprises more than 215 banks, credit unions, neobanks, fintech platforms, and global enterprises. This healthcare contract positions the company’s expansion as a move into an adjacent regulated vertical, rather than a departure from its established market focus.
Key metric — annualised revenue run rate
“Annualised revenue run rate has increased by 2,067% — from approximately A$1.2 million in December 2024 to approximately A$26.0 million.”
Don’t Miss the Next Healthcare Tech Winner
Big News Blast delivers FREE breaking ASX healthcare and tech news directly to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ subscribers already staying ahead of the market. Click the “Free Alerts” button at StockWire X to start receiving alerts the moment market-moving announcements drop.